982 California job cuts precede Actavis, Allergan merger
This article was originally published in Scrip
Executive Summary
Before the quickly negotiated $66bn acquisition of Allergan by Actavis to thwart an unwanted deal proposed by Valeant Pharmaceuticals, Allergan began executing its well-known plan to cut jobs in California and Actavis had its own layoffs under way in the Golden State.